JNHMF (Jack Nathan Medical) YoY EBITDA Growth: -175.00% (As of Oct. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Jack Nathan Medical YoY EBITDA Growth?

Jack Nathan Medical JNHMF -90.42% YoY EBITDA Growth is -175.00% as of Oct. 2023.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Jack Nathan Medical's YoY EBITDA Growth for the quarter that ended in Oct. 2023 was -175.00%.

Jack Nathan Medical's EBITDA per Share for the three months ended in Oct. 2023 was $-0.01.

Jack Nathan Medical YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Jack Nathan Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jack Nathan Medical YoY EBITDA Growth Chart

Jack Nathan Medical Annual Data
Trend Dec18 Dec19 Jan20 Jan21 Jan22 Jan23
YoY EBITDA Growth
Get a 7-Day Free Trial -1,960.00 100.00 0.00 52.60 32.88

Jack Nathan Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.00 -23.81 37.50 10.00 -175.00

Jack Nathan Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Jack Nathan Medical's YoY EBITDA Growth for the fiscal year that ended in Jan. 2023 is calculated as:

YoY EBITDA Growth (A: Jan. 2023 )
=(EBITDA per Share (A: Jan. 2023 )-EBITDA per Share (A: Jan. 2022 ))/ | EBITDA per Share (A: Jan. 2022 ) |
=(-0.049--0.073)/ | -0.073 |
=32.88 %

Jack Nathan Medical's YoY EBITDA Growth for the quarter that ended in Oct. 2023 is calculated as:

YoY EBITDA Growth (Q: Oct. 2023 )
=(EBITDA per Share (Q: Oct. 2023 )-EBITDA per Share (Q: Oct. 2022 )) / | EBITDA per Share (Q: Oct. 2022 )) |
=(-0.011--0.004)/ | -0.004 |
=-175.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -175.00% mean?
Jack Nathan Medical (JNHMF) has a YoY EBITDA Growth of -175.00% as of Oct. 2023. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Jack Nathan Medical and its competitors.
Is Jack Nathan Medical's YoY EBITDA Growth too high?
Jack Nathan Medical's current YoY EBITDA Growth is -175.00%.
How does Jack Nathan Medical's YoY EBITDA Growth compare to HCA and UHS?
Jack Nathan Medical's YoY EBITDA Growth of -175.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Jack Nathan Medical and its competitors. Jack Nathan Medical's current YoY EBITDA Growth is -175.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jack Nathan Medical stock overvalued right now?
Jack Nathan Medical (JNHMF) has a current YoY EBITDA Growth of -175.00%. The current YoY EBITDA Growth is -175.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Jack Nathan Medical (JNHMF), the current YoY EBITDA Growth is -175.00% as of Oct. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jack Nathan Medical Business Description

Address 6 - 6150 Highway 7, Suite 491, Jack Nathan Health, Woodbridge, ON, CAN, L4H 0R6
Jack Nathan Medical Corp is a provider of primary care medical clinics located in Walmart Supercentres under the Jack Nathan Health brand. The company designs, builds and sets barrier-free medical clinics for physicians in high-density centers, providing patients with an opportunity to receive immediate access to quality care in modern facilities.